Elwood V. Jensen, PhD

Dr. Jensen came to UC in March 2002 from the Karolinska Institute in Stockholm, Sweden, where he was the Nobel Visiting Professor.

He grew up in Springfield, Ohio, where he graduated from Wittenberg College, and received his PhD in organic chemistry from the University of Chicago.

In 1946, he spent a year as a Guggenheim Fellow at the Federal Institute of Technology in ZŸrich, where he first took an interest in the study of steroid hormones. It was during this period that he climbed the Matterhorn, a 14,691-foot peak in the Alps, a feat that has become a metaphor in his personal and professional life for his determined opposition toward the seemingly impossible.

In 1947, Dr. Jensen joined the medical faculty at the University of Chicago, where he carried out his breakthrough research. In 1951 he became one of the original members of the famed Ben May Laboratory for Cancer Research, and was appointed director of the lab in 1969. 

On leave of absence in 1983 through 1988, Dr. Jensen served for five years as worldwide research director for the Ludwig Institute for Cancer Research, based in ZŸrich, and one year as a Fogarty Scholar at the National Institutes of Health.

After retirement from Chicago in 1990, he was scholar-in-residence at Cornell Medical College, Alexander von Humboldt visiting professor at the University of Hamburg, and Nobel Visiting Professor at the Karolinska Institute in Stockholm.

Dr. Jensen is now a distinguished university professor in the Department of Cell Biology, Neurobiology and Anatomy at the UC Medical Center's Vontz Center for Molecular Studies. He is collaborating with his colleague and friend Sohaib Khan, PhD, professor of cell biology in the Department of Cell Biology, Neurobiology and Anatomy, to elaborate the mechanism of estrogen actions. 

Besides being a member of the National Academy of Sciences (1974), the pinnacle of a career in science in the United States, Dr.  Jensen holds four honorary degrees. His 25 scientific prizes include the 2002 Brinker International Award from the Susan G. Komen Breast Cancer Foundation, which he received while on the faculty of UC.

He also holds the George J. and Elizabeth Wile Chair in Cancer Research.

Last December, more than 300 top cancer researchers and hormone scientists came to Cincinnati to the Jensen Symposium on Nuclear Receptors and Endocrine Disorders. The meeting, sponsored by UC Medical Center in Dr. Jensen's honor, was one of the largest ever gatherings of the world's leading scientists in the field to discuss how hormones influence heart disease and cancers of the breast, prostate and thyroid.

Tags

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

2

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.